Study with 1,800 first-time moms found no added benefit of screening proteins from blood samples in early pregnancy.
Pr Press Articles, Journals and News
Latest News
From adversity to advocacy, Ohio State Tillman Scholar works for justice for veterans
Eric Sowers, The Ohio State University’s 11th Tillman Scholar, was inspired by the scholarship’s namesake and his call to service following 9/11.
Ohio State No. 4 in national ranking of partner-friendly research universities
The Ohio State University’s Columbus campus places No. 4 overall on a national ranking of “partner-friendly” hiring practices by top-tier research universities.
NIH researchers discover a new face-detecting brain circuit
The findings in non-human primates could shed light on how our brains develop facial recognition skills.
الأدوية التي تقتل الخلايا "الشائخة" قد تفيد بعض النساء الأكبر سنًا، ولكن ليس جميعهن، حسب ما توصلت إليه دراسة أجرتها مايو كلينك
وجد الباحثون في مايو كلينك أن الأدوية التي تقتل الخلايا الهرمة بشكل انتقائي قد تفيد النساء الأكبر سنًا الصحيحات ولكنها ليست علاجًا "يصلح للجميع". وبشكل خاص، قد تفيد هذه الأدوية فقط الأشخاص الذين لديهم عدد كبير من الخلايا الهرمة، وفقًا للنتائج المنشورة اليوم في دورية "Nature Medicine".
Medicamentos que matan celulas "zombis" pueden beneficiar a algunas mujeres mayores, pero no a todas, segun el estudio de Mayo Clinic
Medicamentos que matan selectivamente las celulas senescentes pueden beneficiar a las mujeres mayores sanas, pero no se trata de un medicamento "estandarizado", segun descubrieron de los investigadores de Mayo Clinic.
Medicamentos que matam celulas "zumbis" podem beneficiar algumas mulheres mais velhas, mas nao todas, segundo o estudo da Mayo Clinic
Medicamentos que matam celulas senescentes de forma seletiva podem beneficiar mulheres mais velhas saudaveis, mas nao se trata de um remedio "padronizado", foi o que descobriram os pesquisadores da Mayo Clinic.
Drugs that kill "zombie" cells may benefit some older women, but not all, Mayo Clinic study finds
Drugs that selectively kill senescent cells may benefit otherwise healthy older women but are not a "one-size-fits-all" remedy, Mayo Clinic researchers have found. Specifically, these drugs may only benefit people with a high number of senescent cells, according to findings publishing July 2 in Nature Medicine.
A new target for treatment of one type of macular degeneration
A new study in mice hints at the promise of an eventual alternative treatment option for the “wet” version of age-related macular degeneration (AMD).
Umbilical cord milking does not appear to increase risk of neurodevelopmental delay in non-vigorous infants
NIH-funded study suggests blood-sparing treatment a safe alternative to current standard.
